ECULIZUMAB for Thrombotic microangiopathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 1,312 adverse event reports in the FDA FAERS database where ECULIZUMAB was used for Thrombotic microangiopathy.

Most Reported Side Effects for ECULIZUMAB

Side Effect	Reports	%	Deaths	Hosp.
Fatigue	4,858	11.0%	91	944
Off label use	4,228	9.6%	577	658
Haemoglobin decreased	3,028	6.9%	127	1,045
Headache	2,699	6.1%	56	700
Death	2,221	5.0%	2,221	540
Pyrexia	1,948	4.4%	128	1,129
Dyspnoea	1,819	4.1%	97	737
Asthenia	1,732	3.9%	95	627
Drug ineffective	1,644	3.7%	164	472
Nausea	1,579	3.6%	47	516
Malaise	1,562	3.5%	91	591
Platelet count decreased	1,502	3.4%	111	659
Haemolysis	1,476	3.3%	87	557
Hospitalisation	1,345	3.0%	75	1,336
Blood lactate dehydrogenase increased	1,290	2.9%	79	420